齐拉西酮

奥氮平组的体质量、体质量指数、空腹血糖、胰岛素、胰岛素抵抗指数和低密度脂蛋白的增加要显著高于齐拉西酮组（P均0.05）。

The increases of body weight , FBS , INS , and LDL in the olanzapine group were significantly greated than those in the ziprasidone group .

齐拉西酮与利培酮治疗精神分裂症疗效的Meta分析

Meta-analysis of the effectiveness of ziprasidone and risperidone in treatment of schizophrenia

奎硫平及齐拉西酮对心电图QTc影响的研究奎硫平与利培酮治疗精神分裂症患者对照研究

Comparative Study of Electrocardiogram QTc between Seroquel and Ziprasidone in the Treatment of Schizophrenia

齐拉西酮组和舒必利组均出现较多的不良反应是失眠、头晕和厌食，但两组间差异无显著性（P＞0.05）。

The uneven Russey alkone group and Shu Bili the group present many side effects is losing sleep is dizzy and losses of appetite , but two groups of differences do not have the significance ( P > 0.05 ) .

齐拉西酮对心电图QTc影响的研究

Influence of Ziprasidone on Electrocardiogram QTc

结论：齐拉西酮用于精神分裂症的治疗是有效而安全的，治疗剂量范围为60-160mg·d-1，起始治疗剂量为20mg·d-1（进餐时服）。

CONCLUSION : Ziprasidone is effective and safety in the treatment of schizophrenia . The daily dose range is from 60 mg · d-1 to 160 mg · d-1 , po , bid .

齐拉西酮合并阿米替林治疗难治性抑郁症的临床研究

A clinical study on ziprasidone combined with amitriptyline in treatment-refractory depression

盐酸齐拉西酮和氟哌啶醇对精神分裂症认知灵活性的疗效比较

Effect of ziprasidone hydrochloride and haloperidol on cognitive flexibility in schizophrenia

国产齐拉西酮的急性毒性作用的实验研究

Experimental study of acute toxicity of domestic ziprasidone in mice

盐酸齐拉西酮中空微球的制备及其药代动力学研究

Study on Preparation and Pharmacokinetics of Ziprasidone Hydrochloride Hollow Microspheres

国产甲磺酸齐拉西酮注射液治疗精神分裂症急性激越症状疗效观察

Domestic ziprasidone mesylate injection in the treatment of acute agitation of schizophrenia

齐拉西酮对精神分裂症患者生活质量的影响

Effect of ziprasidone on quality of life of schizophrenic patients

齐拉西酮治疗女性精神分裂症30例的疗效及不良反应

Efficacy and adverse reactions of ziprasidone in 30 female patients with schizophrenia

齐拉西酮与氯丙嗪对首发精神分裂症病人认知功能影响比较

Influence of ziprasidone and chlorpromazine on cognitive function in patients with first-onset schizophrenia

齐拉西酮治疗单纯型精神分裂症的对照研究

Comparative study on simple type schizophrenia treated by ziprasidone

齐拉西酮、氯氮平治疗的卫生经济学比较

Health economic impact of ziprasidone and clozapine in the treatment of refractory schizophrenia

齐拉西酮治疗儿童首发精神分裂症52例

Ziprasidone Treatment of Childhood First-Episode Schizophrenia in 52 cases

齐拉西酮分子印迹聚合物的制备及其识别特性

Preparation and recognition of ziprasidone molecularly imprinted polymer

齐拉西酮与氯氮平治疗女性难治性精神分裂症对照研究

A control study of ziprasidone vs clozapine in the treatment of female refractory schizophrenia

国产齐拉西酮与氟哌啶醇注射液治疗精神分裂症急性激越症状的对照研究

A comparative study of intramuscular ziprasidone and haloperidol in treating acute agitation in schizophrenia

齐拉西酮与喹硫平治疗精神分裂症疗效和安全性比较

The comparation of effects and security of ziprasidone and quetiapine in the treatment of schizophrenia

齐拉西酮与奋乃静治疗精神分裂症的近期疗效与安全性比较

Comparision of short term efficacy and safety between ziprasidone and perphenazine in treatment of schizophrenia

齐拉西酮与阿立呱唑治疗以阴性症状为主的精神分裂症对照研究

A Comparative Study of Ziprasidone and Aripiprazole in the Treatment of Schizophrenia with Predominantly Negative Symptoms

齐拉西酮联用氟伏沙明治疗难治性抑郁症的临床对照研究

A comparison analysis on the efficacy of fluvoxamine combined with ziprasidone in the treatment of refractory depression

目的：通过与利培酮的对比，评价齐拉西酮治疗精神分裂症的临床疗效及安全性。

ObjectiveTo evaluate the clinical curative effect and security of Ziprasidone and Risperidone in the treatment of schizophrenia .

齐拉西酮与舒必利对精神分裂症患者生活质量影响的比较

Contrast Observation of Comparing Ziprasidone with Sulpiride on the Effect of Improving Schizophrenic Patients ' Quality of Life

在一项用氟哌啶醇做对照的研究中，阿立哌唑和齐拉西酮并未导致更明显的体重增加。

In studies using Haldol as the comparator , Abilify and Geodon did not lead to more weight gain .

目的探讨齐拉西酮与奎硫平对老年性精神分裂症的疗效和不良反应。

Objective To study the curative effect and side-effect of ziprasidone and quetiapine in treating patients with senile psychosis .

结论对于肥胖以及有心脑血管疾病的老年患者，可以考虑使用齐拉西酮，以提高临床安全性。

Conclusion For the aim of enhancing clinical safety , fat and CCVD patients can choose ziprasidone for therapy .

目的比较齐拉西酮和奎硫平与奋乃静合并用药对精神分裂症的治疗效果和安全性。

Objective To compare the curative effect and safety of ziprasidone and quetiapine combined with perphenazine in treating schizophrenia .